InMode (INMD) Net Shares Issued and Repurchased (2018 - 2026)
InMode's (INMD) quarterly Net Shares Issued and Repurchased came in at -$87.8 million in Q2 2026, up 31.14% year-over-year from -$66.9 million in Q2 2025, and down 180.89% quarter-over-quarter from -$31.2 million in Q1 2026.
Powered by 
Analysis
InMode (INMD) Net Shares Issued and Repurchased (2018 - 2026) Analysis & Trends
InMode has disclosed Net Shares Issued and Repurchased across 8 years of filings, most recently posting -$87.8 million for Q2 2026.
- In Q2 2026, Net Shares Issued and Repurchased rose 31.14% year-over-year to -$87.8 million; the TTM figure through Jun 2026 stood at -$87.8 million (up 31.14% YoY), while the FY2025 annual figure was -$127.4 million, up 55.34% from the prior year.
- Net Shares Issued and Repurchased came in at -$87.8 million for Q2 2026 at InMode, down from -$31.2 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of -$31.2 million in Q1 2026 to a low of -$285.4 million in Q4 2024.
- Average Net Shares Issued and Repurchased over 4 years is -$100.9 million, with a median of -$89.0 million recorded in 2024.
- Year-over-year, Net Shares Issued and Repurchased slumped 4834.84% in 2022 and jumped 68.75% in 2026.
- Over 4 years, Net Shares Issued and Repurchased stood at -$42.6 million in 2022, then tumbled by 569.34% to -$285.4 million in 2024, then jumped by 55.34% to -$127.4 million in 2025, then surged by 31.14% to -$87.8 million in 2026.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were -$87.8 million in Q2 2026, -$31.2 million in Q1 2026, and -$127.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | InMode | 944.68 Mn | 462.56 Mn | 71.52 Mn | -87.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -87.75 Mn |
| Mar 31, 2026 | -31.24 Mn |
| Dec 31, 2025 | -127.44 Mn |
| Sep 30, 2025 | -127.44 Mn |
| Jun 30, 2025 | -127.44 Mn |
| Mar 31, 2025 | -99.96 Mn |
| Dec 31, 2024 | -285.39 Mn |
| Sep 30, 2024 | -165.54 Mn |
| Jun 30, 2024 | -88.98 Mn |
| Dec 31, 2022 | -42.64 Mn |
| Sep 30, 2022 | -42.64 Mn |
| Jun 30, 2022 | -42.64 Mn |
| Mar 31, 2022 | -42.64 Mn |
| Dec 31, 2021 | -35.37 Mn |
| Sep 30, 2021 | -11.92 Mn |
| Jun 30, 2021 | -11.92 Mn |
| Mar 31, 2021 | -864,000.00 |
| Dec 31, 2020 | -17.22 Mn |
| Dec 31, 2019 | 190,529.00 |
| Dec 31, 2018 | 44,720.00 |